DOCSLIB.ORG

Achondroplasia Hypochondroplasia (PDF)

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Achondroplasia Hypochondroplasia (PDF) ACHONDROPLASIA/HYPOCHONDROPLASIA Achondroplasia (ACH) is characterized by abnormal bone growth that results in For More Information short stature with disproportionately short arms and legs, a large head, and characteristic facial features. Intelligence and life span are usually unaffected, Online Mendelian Inheritance in Man http://www.ncbi.nlm.nih. although compression of the spinal cord and/or upper airway obstruction during gov/omim/ ACH Item # 100800, infancy may result in medical complications. HCH Item # 146000 Hypochondroplasia (HCH) is also characterized by short stature with GeneReviews online clinical disproportionately short arms and legs. The skeletal features are very similar to information resource - ACH: Achondroplasia but usually tend to be milder. Medical problems common to http://www.ncbi.nlm.nih.gov/ Achondroplasia occur less frequently in Hypochondroplasia, however deficits in bookshelf/br.fcgi?book=gene& mental capacity may be more common. part=achondroplasia or HCH: http://www.ncbi.nlm.nih.gov/ bookshelf/br.fcgi?book=gene GENETICS TEST METHODS &part=hypochondroplasia Achondroplasia and Hypochondroplasia are ● Direct mutation detection assay To locate a genetics center near autosomal dominant disorders caused by using PCR to test for the following you, please visit the Canadian mutations in the fibroblast growth factor mutations in the FGFR3 gene: Association of Genetic receptor 3 (FGFR3) gene located on Counsellors website at chromosome 4 (4p16.3). Both conditions Disorder FGFR3 Gene Mutation www.cagc-accg.ca or the National Society of Genetic occur as a result of different changes in the c.1138G>A (p.Gly380Arg) Counsellors website at FGFR3 gene. ACH c.1138G>C (p.Gly380Arg) www.nsgc.org Most cases of ACH or HCH are a result of a c.1123G>T (p.Gly375Cys) new mutation, as the parents are not c.1620C>A (p.Asn540Lys) affected and have average stature. In these cases the risk of having another affected c.1620C>G (p.Asn540Lys) HCH child is low. A person with ACH or HCH c.1619A>C (p.Asn540Thr) whose partner is average-sized has a 50% chance of having a child with the same c.1612A>G (p.Ile538Val) condition. When both parents are affected, 1. Current molecular testing there is a 75% chance of having an affected TEST SENSITIVITY may not detect all possible child. The severity of the disorder in these The mutations indicated above mutations for this disease. A children will vary, depending on the type account for more than 99% of those negative test does not rule out and number of mutations inherited. the possibility of ACH or HCH. present in individuals affected with Achondroplasia, and 70% of those WHO SHOULD BE TESTED? 2. Test results should be present in individuals affected with interpreted in the context of ● Individuals clinically suspected of being Hypochondroplasia. A small fraction clinical findings, family history affected with ACH or HCH of people with ACH and ~30% of and other laboratory data. ● Pregnancies at high risk due to abnormal people with HCH have different ultrasound findings or a family history of mutations in the FGFR3 gene that 3. Other mutation combinations ACH or HCH are not detected by this test. are possible in addition to those listed. These combinations are very rare and usually result in a Potential Outcomes & Interpretation of Test Results more serious phenotype. 4. This test was developed and FGFR3 Gene Mutation Explanation its performance characteristics validated by the Genome None detected This result does not support a diagnosis of Diagnostics Laboratory at the Achondroplasia or Hypochondroplasia Hospital for Sick Children. It has not been cleared or Mutation detected This result supports a diagnosis approved by the U.S. Food and (Gly380Arg or Gly375Cys) of Achondroplasia Drug Administration. The FDA has determined that such Mutation detected (Asn540Thr, This result supports a diagnosis clearance or approval is not Asn540Lys or Ile538Val) of Hypochondroplasia necessary. This test is used for clinical purposes. OMG1620B/02 .
Load more

Recommended publications
  • Repercussions of Inborn Errors of Immunity on Growth☆ Jornal De Pediatria, Vol
    Jornal de Pediatria ISSN: 0021-7557 ISSN: 1678-4782 Sociedade Brasileira de Pediatria Goudouris, Ekaterini Simões; Segundo, Gesmar Rodrigues Silva; Poli, Cecilia Repercussions of inborn errors of immunity on growth☆ Jornal de Pediatria, vol. 95, no. 1, Suppl., 2019, pp. S49-S58 Sociedade Brasileira de Pediatria DOI: https://doi.org/10.1016/j.jped.2018.11.006 Available in: https://www.redalyc.org/articulo.oa?id=399759353007 How to cite Complete issue Scientific Information System Redalyc More information about this article Network of Scientific Journals from Latin America and the Caribbean, Spain and Journal's webpage in redalyc.org Portugal Project academic non-profit, developed under the open access initiative J Pediatr (Rio J). 2019;95(S1):S49---S58 www.jped.com.br REVIEW ARTICLE ଝ Repercussions of inborn errors of immunity on growth a,b,∗ c,d e Ekaterini Simões Goudouris , Gesmar Rodrigues Silva Segundo , Cecilia Poli a Universidade Federal do Rio de Janeiro (UFRJ), Faculdade de Medicina, Departamento de Pediatria, Rio de Janeiro, RJ, Brazil b Universidade Federal do Rio de Janeiro (UFRJ), Instituto de Puericultura e Pediatria Martagão Gesteira (IPPMG), Curso de Especializac¸ão em Alergia e Imunologia Clínica, Rio de Janeiro, RJ, Brazil c Universidade Federal de Uberlândia (UFU), Faculdade de Medicina, Departamento de Pediatria, Uberlândia, MG, Brazil d Universidade Federal de Uberlândia (UFU), Hospital das Clínicas, Programa de Residência Médica em Alergia e Imunologia Pediátrica, Uberlândia, MG, Brazil e Universidad del Desarrollo,
    [Show full text]
  • Craniosynostosis Genetics: the Mystery Unfolds
    Review Article Craniosynostosis genetics: The mystery unfolds Inusha Panigrahi Department of Pediatrics, Genetic and Metabolic Unit, Advanced Pediatric Center, PGIMER, Chandigarh, India The syndromes associated with craniosynostosis Craniosynsostosis syndromes exhibit considerable phenotypic and genetic heterogeneity. Sagittal synostosis include Apert syndrome, Crouzon syndrome, Greig is common form of isolated craniosynostosis. The cephalopolysyndactyly, and Saethre-Chotzen syndrome. sutures involved, the shape of the skull and associated malformations give a clue to the specific diagnosis. It is genetically heterogeneous disorder with mutation Crouzon syndrome is one of the most common of the identifi ed in several genes, predominantly the fi broblast craniosynostosis syndromes. Apert syndrome accounts for growth factor receptor genes.[3,4] Saethre-Chotzen 4.5% of all craniosynostoses and is one of the most serious of these syndromes. Most syndromic craniosynostosis syndrome and craniosynostosis (Boston-type) arise require multidisciplinary management. The following review from mutations in the Twist and muscle segment provides a brief appraisal of the various genes involved in craniosynostosis syndromes, and an approach to diagnosis homeobox 2 (MSX2) transcription factors, respectively. and genetic counseling. Rates of neuropsychological defi cits range from 35 to Key words: Apert syndrome, FGFR2 mutations, 50% in school-aged children with isolated single suture hydrocephalus, plagiocephaly, sutural synostosis, craniosynostosis.[5] Secondary effects of craniosynostosis syndromes may include vision problems and increased intracranial pressure, among others. Patients with TWIST gene Introduction mutations may have more ophthalmic abnormalities, including more strabismus, ptosis, and amblyopia.[6] The following discussion gives a comprehensive review Craniosynostosis, premature suture fusion, is one of of different disorders presenting with craniosynostosis, the most common craniofacial anomalies with incidence their diagnosis, and genetic counseling.
    [Show full text]
  • Blueprint Genetics Craniosynostosis Panel
    Craniosynostosis Panel Test code: MA2901 Is a 38 gene panel that includes assessment of non-coding variants. Is ideal for patients with craniosynostosis. About Craniosynostosis Craniosynostosis is defined as the premature fusion of one or more cranial sutures leading to secondary distortion of skull shape. It may result from a primary defect of ossification (primary craniosynostosis) or, more commonly, from a failure of brain growth (secondary craniosynostosis). Premature closure of the sutures (fibrous joints) causes the pressure inside of the head to increase and the skull or facial bones to change from a normal, symmetrical appearance resulting in skull deformities with a variable presentation. Craniosynostosis may occur in an isolated setting or as part of a syndrome with a variety of inheritance patterns and reccurrence risks. Craniosynostosis occurs in 1/2,200 live births. Availability 4 weeks Gene Set Description Genes in the Craniosynostosis Panel and their clinical significance Gene Associated phenotypes Inheritance ClinVar HGMD ALPL Odontohypophosphatasia, Hypophosphatasia perinatal lethal, AD/AR 78 291 infantile, juvenile and adult forms ALX3 Frontonasal dysplasia type 1 AR 8 8 ALX4 Frontonasal dysplasia type 2, Parietal foramina AD/AR 15 24 BMP4 Microphthalmia, syndromic, Orofacial cleft AD 8 39 CDC45 Meier-Gorlin syndrome 7 AR 10 19 EDNRB Hirschsprung disease, ABCD syndrome, Waardenburg syndrome AD/AR 12 66 EFNB1 Craniofrontonasal dysplasia XL 28 116 ERF Craniosynostosis 4 AD 17 16 ESCO2 SC phocomelia syndrome, Roberts syndrome
    [Show full text]
  • A Curated Gene List for Reporting Results of Newborn Genomic Sequencing
    © American College of Medical Genetics and Genomics ORIGINAL RESEARCH ARTICLE A curated gene list for reporting results of newborn genomic sequencing Ozge Ceyhan-Birsoy, PhD1,2,3, Kalotina Machini, PhD1,2,3, Matthew S. Lebo, PhD1,2,3, Tim W. Yu, MD3,4,5, Pankaj B. Agrawal, MD, MMSC3,4,6, Richard B. Parad, MD, MPH3,7, Ingrid A. Holm, MD, MPH3,4, Amy McGuire, PhD8, Robert C. Green, MD, MPH3,9,10, Alan H. Beggs, PhD3,4, Heidi L. Rehm, PhD1,2,3,10; for the BabySeq Project Purpose: Genomic sequencing (GS) for newborns may enable detec- of newborn GS (nGS), and used our curated list for the first 15 new- tion of conditions for which early knowledge can improve health out- borns sequenced in this project. comes. One of the major challenges hindering its broader application Results: Here, we present our curated list for 1,514 gene–disease is the time it takes to assess the clinical relevance of detected variants associations. Overall, 954 genes met our criteria for return in nGS. and the genes they impact so that disease risk is reported appropri- This reference list eliminated manual assessment for 41% of rare vari- ately. ants identified in 15 newborns. Methods: To facilitate rapid interpretation of GS results in new- Conclusion: Our list provides a resource that can assist in guiding borns, we curated a catalog of genes with putative pediatric relevance the interpretive scope of clinical GS for newborns and potentially for their validity based on the ClinGen clinical validity classification other populations. framework criteria, age of onset, penetrance, and mode of inheri- tance through systematic evaluation of published evidence.
    [Show full text]
  • Genetic Disorder
    Genetic disorder Single gene disorder Prevalence of some single gene disorders[citation needed] A single gene disorder is the result of a single mutated gene. Disorder Prevalence (approximate) There are estimated to be over 4000 human diseases caused Autosomal dominant by single gene defects. Single gene disorders can be passed Familial hypercholesterolemia 1 in 500 on to subsequent generations in several ways. Genomic Polycystic kidney disease 1 in 1250 imprinting and uniparental disomy, however, may affect Hereditary spherocytosis 1 in 5,000 inheritance patterns. The divisions between recessive [2] Marfan syndrome 1 in 4,000 and dominant types are not "hard and fast" although the [3] Huntington disease 1 in 15,000 divisions between autosomal and X-linked types are (since Autosomal recessive the latter types are distinguished purely based on 1 in 625 the chromosomal location of Sickle cell anemia the gene). For example, (African Americans) achondroplasia is typically 1 in 2,000 considered a dominant Cystic fibrosis disorder, but children with two (Caucasians) genes for achondroplasia have a severe skeletal disorder that 1 in 3,000 Tay-Sachs disease achondroplasics could be (American Jews) viewed as carriers of. Sickle- cell anemia is also considered a Phenylketonuria 1 in 12,000 recessive condition, but heterozygous carriers have Mucopolysaccharidoses 1 in 25,000 increased immunity to malaria in early childhood, which could Glycogen storage diseases 1 in 50,000 be described as a related [citation needed] dominant condition. Galactosemia
    [Show full text]
  • Original Articles Evidence for Digenic Inheritance in Some Cases of Antley
    26 J Med Genet 2000;37:26–32 Original articles J Med Genet: first published as 10.1136/jmg.37.1.26 on 1 January 2000. Downloaded from Department of Clinical Genetics, Institute of Child Health, 30 Guilford Street, London WC1N 1EH, UK Evidence for digenic inheritance in some cases of W Reardon M Baraitser Antley-Bixler syndrome? R M Winter Molecular Genetics Unit, Institute of Child Health, London, UK William Reardon, Anne Smith, John W Honour, Peter Hindmarsh, Debipriya Das, A Smith Gill Rumsby, Isabelle Nelson, Sue Malcolm, Lesley Adès, David Sillence, I Nelson Dhavendra Kumar, Celia DeLozier-Blanchet, Shane McKee, Thaddeus Kelly, S Malcolm Wallace L McKeehan, Michael Baraitser, Robin M Winter Department of Chemical Pathology, University College London Hospitals, London, UK J W Honour Abstract The Antley-Bixler syndrome represents the D Das The Antley-Bixler syndrome has been severe end of the spectrum of syndromic G Rumsby thought to be caused by an autosomal craniosynostosis. Many such patients have London Centre for recessive gene. However, patients with this choanal atresia and severe respiratory distress, Paediatric often resulting in early death. In contrast with Endocrinology, phenotype have been reported with a new University College dominant mutation at the FGFR2 locus as most clinically similar forms of syndromic Hospital, London, UK well as in the oVspring of mothers taking craniosynostosis, which are transmitted in an P Hindmarsh the antifungal agent fluconazole during autosomal dominant manner, Antley-Bixler Departments of early pregnancy. In addition to the cranio- syndrome has been thought to be an autosomal Clinical Genetics and recessive disorder.7 This is based upon three Paediatrics and Child synostosis and joint ankylosis which are the 8–10 Health, New Children’s clinical hallmarks of the condition, many reports of aVected sibs and the birth of Hospital, Parramatta, patients, especially females, have genital aVected subjects to consanguineous par- NSW 2124, Australia ents.91112It should be noted that joint ankylo- abnormalities.
    [Show full text]
  • Anesthesia Management of Jansen's Metaphyseal Dysplasia
    CASE REPORT East J Med 21(1): 52-53, 2016 Anesthesia management of Jansen’s metaphyseal dysplasia Ugur Goktas1,*, Murat Tekin2, Ismail Kati3 1Department of Anesthesiology, Medical Faculty, Yuzuncu Yil University, Van, Turkey 2Department of Anesthesiology, Medical Faculty, Kocaeli University, Kocaeli, Turkey 3Department of Anesthesiology, Medical Faculty, Gazi University, Ankara, Turkey ABSTRACT Metaphyseal chondrodysplasia is a rare autosomal dominant disorder characterized by accumulation of cartilage in specifically metaphysis of tubular bones. Hyperkalemia and hypophosphatemia were seen most of these patients. In this article we intended to draw attention to some issues releated with anesthesia hereby that a 9 year-old patient with Jansen’s metaphyseal dysplasia. Key Words: general anesthesia, congenital anomalies, drugs Introduction (60%) were used for the anesthesia management. Operation duration was 50 min. LMA was removed Metaphyseal chondrodysplasia is a very rare postoperatively without any problem. Control serum autosomal dominant disorder affected of enchondral potassium and phosphor levels peroperatively and ossification in especially metaphysis (1). Firstly postoperatively were found normal (Table 1). After described in 1934 by Murk Jansen as various severity the recovery patient was sent to the ward without any and degrees (2), and metaphyseal chondrodysplasia problem. was classified in 1957 by Weil. Jansen type, which is the one of the most serious and rare. Hyperkalemia Discussion and hypophosphatemia were seen half of these Jansen type metaphyseal dysplasia is a very rare patients (3,4). In this article we intended to draw and serious disorder in the enchondral ossification attention to some issues related with anesthesia diseases. Affecting the metaphyses such as management that a 9 year-old patient a with Jansen’s achondroplasia, various types of rickets, metaphyseal dysplasia which to be a disorder very rare hypophosphatasia and multiple enchondromatosis and hardest diagnosing.
    [Show full text]
  • Vistara Non-Invasive Prenatal Screen
    Vistara non-invasive prenatal screen Hypochondro- Causes a mild form of dwarsm; up to 80% Vistara identies probability for conditions that may have otherwise gone undetected until after birth plasia may cause seizures with secondary or into childhood. All conditions are inherited in an autosomal or X-linked dominant fashion, which means that FGFR3 developmental delay if the mutation is present, the child will be affected by the condition and experience related symptoms. Intellectual Causes intellectual disability and ~100% disability developmental delays SYNGAP1 Condition1 Clinical Cases Ultrasound ndings2,3 Clinical Detection Gene(s) synopsis2,3 caused by actionability rate for Jackson Weiss A type of craniosynostosis; more de novo None Third Non- gene1 syndrome also causes foot abnormalities severe mutations2,3 trimester specic FGFR2 forms Achondroplasia The most common form 80% Labor and delivery >96% FGFR3 of skeletal dysplasia; may management, monitor Juvenile A rare pediatric blood cancer; ve- unknown cause hydrocephalus, for spinal stenosis, early myelomonocytic year survival is approximately 50% delayed motor milestones, sleep studies to reduce leukemia (JMML) and spinal stenosis risk of SIDS PTPN11 Alagille Affects multiple organ systems 50% to 70% Symptom-based >86% LEOPARD Similar to Noonan syndrome, unknown syndrome and may cause growth problems, treatment syndrome 1,2 with notable brown skin spots JAG1 congenital heart defects, and (Noonan (lentigines); causes short stature, vertebral differences syndrome heart defects, bleeding
    [Show full text]
  • Musculoskeletal Block Pathology Lecture 2
    MUSCULOSKELETAL BLOCK PATHOLOGY LECTURE 2: CONGENITAL AND DEVELOPMENTAL BONE DISEASES Prepared by Dr. Maha Arafah Given by:Dr.Amany Fathaddin 2014 Diseases of Bones Objectives Be aware of some important congenital and developmental bone diseases and their principal pathological features Be familiar with the terminology used in some important developmental and congenital disorders. Understand the etiology, pathogenesis and clinical features of osteoporosis Bone 206 bones organic matrix (35%) and inorganic elements (65%): calcium hydroxyapatite [Ca10(PO4)6(OH)2] The bone-forming cells include osteoblasts and osteocytes, while cells of the bone-digesting lineage are osteoclasts is very dynamic and subject to constant breakdown and renewal: remodeling Diseases of Bones Congenital Acquired Metabolic Infections Traumatic Tumors Congenital Diseases of Bones Localized or entire skeleton Developmental anomalies resulting from Dysostoses: e.g. localized problems in the migration of aplasia mesenchymal cells and the formation of extra bones condensations abnormal fusion of bones Dysplasias: e.g. Osteogenesis imperfecta Achondroplasia Osteopetrosis Osteogenesis imperfecta Congenital Diseases of Bones Osteogenesis imperfecta (brittle bone disease) Osteogenesis imperfecta is a group of inherited diseases characterized by brittle bones Defect in the synthesis of type I collagen leading to too little bone resulting in extreme skeletal fragility with susceptibility to fractures Four main types with different clinical manifestations classified according to the severity of bone fragility, the presence or absence of blue scleras, hearing loss, abnormal dentition, and the mode of inheritance, some are fatal. Type 1: blue sclera in both eye, deformed teeth and hearing loss Osteogenesis imperfecta, type 1 blue scleras brittle bones deformed teeth Osteogenesis imperfecta Skeletal radiograph of a fetus with lethal type 2 osteogenesis imperfecta Achondroplasia Achondroplasia is the most common skeletal dysplasia and a major cause of dwarfism.
    [Show full text]
  • EUROCAT Syndrome Guide
    JRC - Central Registry european surveillance of congenital anomalies EUROCAT Syndrome Guide Definition and Coding of Syndromes Version July 2017 Revised in 2016 by Ingeborg Barisic, approved by the Coding & Classification Committee in 2017: Ester Garne, Diana Wellesley, David Tucker, Jorieke Bergman and Ingeborg Barisic Revised 2008 by Ingeborg Barisic, Helen Dolk and Ester Garne and discussed and approved by the Coding & Classification Committee 2008: Elisa Calzolari, Diana Wellesley, David Tucker, Ingeborg Barisic, Ester Garne The list of syndromes contained in the previous EUROCAT “Guide to the Coding of Eponyms and Syndromes” (Josephine Weatherall, 1979) was revised by Ingeborg Barisic, Helen Dolk, Ester Garne, Claude Stoll and Diana Wellesley at a meeting in London in November 2003. Approved by the members EUROCAT Coding & Classification Committee 2004: Ingeborg Barisic, Elisa Calzolari, Ester Garne, Annukka Ritvanen, Claude Stoll, Diana Wellesley 1 TABLE OF CONTENTS Introduction and Definitions 6 Coding Notes and Explanation of Guide 10 List of conditions to be coded in the syndrome field 13 List of conditions which should not be coded as syndromes 14 Syndromes – monogenic or unknown etiology Aarskog syndrome 18 Acrocephalopolysyndactyly (all types) 19 Alagille syndrome 20 Alport syndrome 21 Angelman syndrome 22 Aniridia-Wilms tumor syndrome, WAGR 23 Apert syndrome 24 Bardet-Biedl syndrome 25 Beckwith-Wiedemann syndrome (EMG syndrome) 26 Blepharophimosis-ptosis syndrome 28 Branchiootorenal syndrome (Melnick-Fraser syndrome) 29 CHARGE
    [Show full text]
  • The Differential Diagnosis of the Short-Limbed Dwarfs Presenting at Birth R
    Postgrad Med J: first published as 10.1136/pgmj.53.618.204 on 1 April 1977. Downloaded from Postgraduate Medical Journal (April 1977) 53, 204-211 The differential diagnosis of the short-limbed dwarfs presenting at birth R. N. MUKHERJI P. D. Moss M.R.C.P., D.C.H. F.R.C.P., D.C.H. Department ofPaediatrics, Royal Infirmary, Blackburn, Lancashire Summary Harris and Patton (1971) reviewed seventeen still- Attention is drawn to the fact that in a number of born or early neonatal deaths originally diagnosed types of short-limbed dwarfism a precise diagnosis can as achondroplastics and showed that in ten of these be made in the neonatal period. Examples are given cases the diagnosis should have been thanatophoric and the prognostic and genetic implications are dis- dwarfism. This supports the view that achondro- cussed. It is important to be able to advise parents of plasia has been over diagnosed at birth and that the the likely outlook for the infant and of the genetic severely affected cases are, in fact, some other type implication. Early diagnosis is therefore not merely of lethal neonatal dwarfism. an academic exercise. Achondrogenesis Introduction This was first described under the title of anosteo- When Rathbun (1948) first described neonatal genesis (Parenti, 1936) as it was thought to be a hypophosphatasia he discussed three conditions of variety of osteogenesis imperfecta. Fraccaro (1952) differential diagnosis. These consisted ofosteogenesis first used the term 'achondrogenesis' because of by copyright. imperfecta, achondroplasia and renal hyperpara- marked retardation of ossification. Parental con- thyroidism. Since then a number of other conditions sanguinity (Saldino, 1971) and multiple affected have been defined on a clinical, radiological and siblings (Houston, Awen and Kent, 1972) have been genetic basis (Tables 1 and 2).
    [Show full text]
  • Achondroplasia and Spinal Cord Lesion. Three Case Reports
    Paraplegia 31 (1993) 375-379 © 1993 International Medical Society of Paraplegia Achondroplasia and spinal cord lesion. Three case reports N Hamamci MD, * S Hawran MD, F Biering-Sprensen MD PhD Centre for Spinal Cord Injured, Rigshospitalet, National University Hospital, Copenhagen, Denmark. The most important complications encountered by achondroplastic dwarfs are neurological problems related to a narrowed spinal canal. Stenosis of the spinal canal is secondary to abnormalities of endochondral ossification with premature synostosis of the ossification centres of the vertebral body and the posterior arch, resulting in thickening of the lamina, shortening of the pedicles, and reduced height of the vertebral bodies. Additional factors such as prolapsed intervertebral discs, osteophytes and progressive thoracolumbar kyphosis con­ tribute to the narrowing of the spinal canal. Three achondroplastic dwarfs having spinal stenosis and spinal cord lesion representing typical clinical courses are described. Keywords: achondroplasia; dwarfism; spinal cord injury; spinal canal stenosis. Introduction and the vertebral bodies reduced in height. Thus the spinal canal is narrowed both Achondroplasia, the most common form of anteroposteriorly and transversely (Fig 1). osteochondrodysplasia, is autosomal domin­ The spinal subarachnoid space is further ant with most cases being new mutations. It reduced because the vertebral bodies are is characterised by rhizomelic shortness of concave in their posterior aspect with the the limbs, midface hypoplasia and defective upper and lower surfaces projecting into the endochondral bone development. 1-3 space of the vertebral canal. 3 There is a high incidence of neural This report describes three achondro­ complications associated with this form of plastic dwarfs suffering from spinal stenosis dwarfism.4 Neural complications are pres­ and incomplete SCI who were admitted to ent in about 50% of the patients and include our centre within a period of 3 years.
    [Show full text]